Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $0.75 in the prior trading day, Seres Therapeutics Inc (NASDAQ: MCRB) closed at $0.67, down -10.50%. In other words, the price has decreased by -$10.50 from its previous closing price. On the day, 2.59 million shares were traded.
Ratios:
Our goal is to gain a better understanding of MCRB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.12 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 3.91 whereas as Long-Term Debt/Eq ratio is at 3.56.
On April 21, 2023, JP Morgan started tracking the stock assigning a Neutral rating and target price of $7.JP Morgan initiated its Neutral rating on April 21, 2023, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 18 ’25 when Young Teresa L. sold 3,338 shares for $0.81 per share. The transaction valued at 2,704 led to the insider holds 97,536 shares of the business.
Henn Matthew R. sold 3,953 shares of MCRB for $3,204 on Feb 18 ’25. The insider now owns 84,443 shares after completing the transaction at $0.81 per share. On Feb 18 ’25, another insider, Shaff Eric D., who serves as the CEO and President of the company, sold 12,726 shares for $0.81 each. As a result, the insider received 10,314 and left with 192,039 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1906.84 while its Price-to-Book (P/B) ratio in mrq is 4.77.
Stock Price History:
Over the past 52 weeks, MCRB has reached a high of $1.53, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is -18.87%, while the 200-Day Moving Average is calculated to be -24.07%.
Shares Statistics:
A total of 170.20M shares are outstanding, with a floating share count of 124.81M. Insiders hold about 26.90% of the company’s shares, while institutions hold 23.42% stake in the company.
